Sonoma Pharmaceuticals to Present at the H.C. Wainwright Bioconnect 2021 Virtual ConferenceBusiness Wire • 01/11/21
ROSEN, A LEADING INVESTOR FIRM, Continues To Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. – SNOABusiness Wire • 12/24/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOAGlobeNewsWire • 12/20/20
Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental MarketsBusiness Wire • 12/17/20
Sonoma Pharmaceuticals and Crown Laboratories Announce an Exclusive Partnership to Launch Microcyn® Technology-Based Anti-Itch Over-the-Counter ProductsBusiness Wire • 12/10/20
ROSEN, GLOBAL INVESTOR COUNSEL, Continues Its Investigation of Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOANewsfile Corp • 12/08/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sonoma Pharmaceuticals, Inc. – SNOAGlobeNewsWire • 12/01/20
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 11/27/20
Sonoma Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law FirmGlobeNewsWire • 11/26/20
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmNewsfile Corp • 11/25/20
ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOAPRNewsWire • 11/25/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 11/24/20
ROSEN, RESPECTED INVESTOR COUNSEL, Continues to Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOANewsfile Corp • 11/24/20
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Sonoma Pharmaceuticals, Inc. – SNOABusiness Wire • 11/24/20
Sonoma Pharmaceuticals and MicroSafe Group Announce that Health Canada Authorized Nanocyn® Disinfectant & Sanitizer to be Sold in Canada as a Hard-Surface Disinfectant under COVID-19 Interim MeasureBusiness Wire • 09/17/20
Sonoma Pharmaceuticals and Te Arai BioFarma Announce Launch of Two New Microcyn® Technology Products in Australia – Nasocyn® Nasal Care and Oracyn® Oral CareBusiness Wire • 09/09/20
Sonoma Pharmaceuticals and MicroSafe Group Announce That Microsafe® Disinfectant & Sanitizer Manufactured Using Sonoma’s Microcyn® Technology Successfully Passed Material Compatibility Testing for Both Airbus and Boeing Commercial Transport AircraftBusiness Wire • 07/28/20
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2020 Financial ResultsBusiness Wire • 07/10/20